Damora Therapeutics, Inc. (DMRA) vs OPKO Health, Inc. (OPK)
A side-by-side comparison of Damora Therapeutics, Inc. and OPKO Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DMRA
Damora Therapeutics, Inc.
$18.97HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
OPK
OPKO Health, Inc.
$1.51HealthcareDelayed quote: Oct 6, 2026, 12:49 PM EDT
Total return — DMRA vs OPK
growth of $100 · dividends reinvested · last 6yDMRA -94.6% (-38.5%/yr)OPK -60.7% (-14.4%/yr)OPK compounded faster over this window
Log scale — wide-divergence pair
DMRA OPK
DMRA vs OPK: by the numbers
- •DMRA is the larger company ($1.17B vs $1.12B market cap).
- •Both run net losses; DMRA's is the smaller (0.00% vs -12.40% net margin).
Metrics side by side
Valuation
| Metric | DMRA | OPK |
|---|---|---|
| P/S ratio | N/A | 1.91 |
| P/B ratio | 3.02 | 0.95 |
Profitability
| Metric | DMRA | OPK |
|---|---|---|
| Gross margin | 0.00% | 21.10% |
| Operating margin | 0.00% | -36.08% |
| Net margin | 0.00% | -12.40% |
| ROE | -50.93% | -6.16% |
| ROIC | -52.44% | -8.86% |
Growth (annualized)
| Metric | DMRA | OPK |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -21.00% |
| Total return CAGR (5Y) | -25.05% | -15.39% |
Frequently asked
- How have DMRA and OPK total returns compared?
- Over the past 5 years, DMRA delivered -25.05% and OPK delivered -15.39% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.